The OncoDaily – Northeast GI Oncology Congress 2026 will take place from November 19–21, 2026, in Boston, Massachusetts, USA.

Organized by OncoDaily, the congress will bring together experts across gastrointestinal oncology to connect advances in biomarkers, targeted therapies, immunotherapy, liquid biopsy, and emerging treatment modalities across GI cancer types.

The congress is designed around a single-track programme, allowing participants across specialties to engage with the same discussions rather than choosing between parallel sessions. The programme spans basic and translational research, multidisciplinary clinical practice, access and equity, quality of life, and patient-partnered research.

Sessions will cover upper GI, pancreatic and biliary, and lower GI cancers, alongside cross-cutting discussions on topics including ctDNA and MRD, CLDN18.2, HER2, FGFR2b, RAS, KRAS G12D, targeted therapies, immunotherapy, ADCs, T-cell therapies, personalized vaccines, and treatment resistance. The meeting will also feature patient advocacy, mentorship opportunities, young investigator presentations, rapid-fire sessions, debates, and poster discussions.